Stephen Shuttleworth  Chief Operating Officer and Chief Scientific Officer

Stephen joined Karus as CSO in 2008, and in 2017 was appointed COO. He is the founding scientist of the company’s PI3K-p110β/δ and HDAC6 programs. Previously, he held R&D leadership positions in UK and North American…

Read more

Penny Ward  Chief Medical Officer

Penny has over two decades of experience in clinical development and medical affairs, having held senior management/therapeutic area head roles in Pharmacia and Upjohn, Roche, GSK and UCB. She was previously CMO at Novimmune, Glenmark and Topivert…

Read more

Simon Jones  Chief Financial Officer

Simon joined Karus in 2012. After graduating in Physics from the University of Warwick, he qualified as a Chartered Accountant in 1992 with the international accountancy firm, Ernst & Young and subsequently held positions in a number…

Read more

Elisabeth Bone  Head of Pre-clinical Development

Liz graduated in Natural Sciences from the University of Cambridge and was awarded a PhD in Biochemistry/Molecular Pharmacology from Sheffield University. She held various postdoctoral positions in the UK (Birmingham and Manchester) and …

Read more

Philip Beer  Head of Translational Medicine

Philip is a physician scientist with expertise in cancer biology and precision oncology. He trained as a clinical haematologist at Imperial College, London, where he developed specialist knowledge around the laboratory diagnosis and treatment of h…

Read more